Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Jaime Rojas-Hernández"'
Autor:
Luis Alberto Henríquez-Hernández, Jaime Rojas-Hernández, Domingo J. Quintana-Hernández, Lucas F. Borkel
Publikováno v:
Toxics, Vol 11, Iss 2, p 148 (2023)
Psychedelics are experiencing a strong renaissance and will soon be incorporated into clinical practice. However, there is uncertainty about how much harm they can cause at what doses. This review aimed to collect information on the health-hazardous
Externí odkaz:
https://doaj.org/article/5c2a0a207d6745b3a14afeca54d97654
Autor:
Domingo J. Quintana-Hernández, Jaime Rojas-Hernández, Angelo Santana-del Pino, Carmen Céspedes Suárez, Mónica Pellejero Silva, María Teresa Miró-Barrachina, Ignacio Ibáñez Fernández, José Antonio Estupiñán López, Lucas F. Borkel
Publikováno v:
Journal of Alzheimer's Disease. 91:471-481
Background: This longitudinal study addressed whether mindfulness practice prevents psychological and behavioral symptoms, especially mood disorders, in Alzheimer’s disease (AD). Objective: To assess the incidence of depression in the course of AD
Autor:
Domingo Jesús, Quintana Hernández, María Teresa, Miró Barrachina, Ignacio, Ibáñez Fernández, Angelo, Santana del Pino, Jaime, Rojas Hernández, Javier, Rodríguez García, María del Pino, Quintana Montesdeoca
Publikováno v:
Revista espanola de geriatria y gerontologia. 50(4)
A longitudinal study was conducted in order to analyze the feasibility, safety, and effects of the practice of mindfulness, relaxation and cognitive stimulation on the evolution of Alzheimer's disease, with the aim of testing the equivalence of these
Autor:
Domingo Jesús, Quintana Hernández, María Teresa, Miró Barrachina, Ignacio, Ibáñez Fernández, Angelo Santana, del Pino, Javie r, García Rodríguez, Jaime Rojas, Hernández
Publikováno v:
Revista espanola de geriatria y gerontologia. 49(4)
The purpose of this research was to assess effects of a mindfulness based neuropsychological intervention on the clinical course of Alzheimer's disease.A two year randomized and double blind clinical trial was conducted on 127 probable Alzheimer's di